Literature DB >> 17617112

Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan.

Iwao Ikai1, Shigeki Arii, Masatoshi Okazaki, Kiwamu Okita, Masao Omata, Masamichi Kojiro, Kenichi Takayasu, Yasuni Nakanuma, Masatoshi Makuuchi, Yutaka Matsuyama, Morito Monden, Masatoshi Kudo.   

Abstract

In the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan, 18 213 individuals were newly registered as patients with primary liver cancer at 645 medical institutions over a period of 2 years (from 1 January 2002 to 31 December 2003). Of these patients, 94.2% had hepatocellular carcinoma (HCC) and 4.1% had intrahepatic cholangiocarcinoma (ICC). In addition, 24 705 follow-up patients were registered in the survey. Epidemiological and clinicopathological factors, diagnosis and treatment were investigated in the newly registered patients, and the cumulative survival rates of newly registered patients in the 12th to 17th follow-up surveys conducted between 1992 and 2003 were calculated for each histological type (HCC, ICC, and combined HCC and ICC) and stratified by background factors and treatment. The data obtained in this follow-up survey should contribute to future research and medical practice for primary liver cancer.

Entities:  

Year:  2007        PMID: 17617112     DOI: 10.1111/j.1872-034X.2007.00119.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  132 in total

1.  Impact of clinically significant portal hypertension on surgical outcomes for hepatocellular carcinoma in patients with compensated liver cirrhosis: a propensity score matching analysis.

Authors:  Chul Woo Jang; Hyung Jun Kwon; Horyon Kong; Heontak Ha; Young Seok Han; Jae Min Chun; Sang Geol Kim; Yun Jin Hwang
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2016-11-30

Review 2.  Image-guided percutaneous ablation therapies for hepatocellular carcinoma.

Authors:  Shuichiro Shiina
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

3.  Surgical outcomes and clinical characteristics of elderly patients undergoing curative hepatectomy for hepatocellular carcinoma.

Authors:  Fumitoshi Hirokawa; Michihiro Hayashi; Yoshiharu Miyamoto; Mitsuhiro Asakuma; Tetsunosuke Shimizu; Koji Komeda; Yoshihiro Inoue; Atsushi Takeshita; Yuro Shibayama; Kazuhisa Uchiyama
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

4.  Recent trends in hepatectomy for elderly patients with hepatocellular carcinoma.

Authors:  Masaki Ueno; Shinya Hayami; Masaji Tani; Manabu Kawai; Seiko Hirono; Hiroki Yamaue
Journal:  Surg Today       Date:  2013-10-05       Impact factor: 2.549

Review 5.  Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china.

Authors:  Peipei Song; Jianjun Gao; Yoshinori Inagaki; Norihiro Kokudo; Kiyoshi Hasegawa; Yasuhiko Sugawara; Wei Tang
Journal:  Liver Cancer       Date:  2013-01       Impact factor: 11.740

6.  Role of liver resection in the management of multinodular hepatocellular carcinoma.

Authors:  Osman Abbasoglu
Journal:  World J Hepatol       Date:  2015-09-18

7.  Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma.

Authors:  Bao-Hong Yuan; Wei-Ping Yuan; Ru-Hong Li; Bang-De Xiang; Wen Feng Gong; Le-Qun Li; Jian-Hong Zhong
Journal:  Tumour Biol       Date:  2015-09-17

8.  Epidemiology of hepatocellular carcinoma in Japan.

Authors:  Takeji Umemura; Tetsuya Ichijo; Kaname Yoshizawa; Eiji Tanaka; Kendo Kiyosawa
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

9.  Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic.

Authors:  Myron J Tong; Hai-En Sun; Carlos Hsien; David S K Lu
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

10.  Etiology of liver cirrhosis in Japan: a nationwide survey.

Authors:  Kojiro Michitaka; Shuhei Nishiguchi; Yutaka Aoyagi; Yoichi Hiasa; Yoshio Tokumoto; Morikazu Onji
Journal:  J Gastroenterol       Date:  2009-09-30       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.